These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
385 related articles for article (PubMed ID: 26177500)
1. EphA2 Is a Potential Player of Malignant Cellular Behavior in Non-Metastatic Renal Cell Carcinoma Cells but Not in Metastatic Renal Cell Carcinoma Cells. Cho MC; Cho SY; Yoon CY; Lee SB; Kwak C; Kim HH; Jeong H PLoS One; 2015; 10(7):e0130975. PubMed ID: 26177500 [TBL] [Abstract][Full Text] [Related]
2. Silencing of lysyl oxidase‑like 2 inhibits the migration, invasion and epithelial‑to‑mesenchymal transition of renal cell carcinoma cells through the Src/FAK signaling pathway. Hong X; Yu JJ Int J Oncol; 2019 May; 54(5):1676-1690. PubMed ID: 30816490 [TBL] [Abstract][Full Text] [Related]
3. miR-141 is a key regulator of renal cell carcinoma proliferation and metastasis by controlling EphA2 expression. Chen X; Wang X; Ruan A; Han W; Zhao Y; Lu X; Xiao P; Shi H; Wang R; Chen L; Chen S; Du Q; Yang H; Zhang X Clin Cancer Res; 2014 May; 20(10):2617-30. PubMed ID: 24647573 [TBL] [Abstract][Full Text] [Related]
4. Hypoxia-induced overexpression of stanniocalcin-1 is associated with the metastasis of early stage clear cell renal cell carcinoma. Ma X; Gu L; Li H; Gao Y; Li X; Shen D; Gong H; Li S; Niu S; Zhang Y; Fan Y; Huang Q; Lyu X; Zhang X J Transl Med; 2015 Feb; 13():56. PubMed ID: 25740019 [TBL] [Abstract][Full Text] [Related]
5. CXC chemokine receptor 4 is essential for maintenance of renal cell carcinoma-initiating cells and predicts metastasis. Gassenmaier M; Chen D; Buchner A; Henkel L; Schiemann M; Mack B; Schendel DJ; Zimmermann W; Pohla H Stem Cells; 2013 Aug; 31(8):1467-76. PubMed ID: 23630186 [TBL] [Abstract][Full Text] [Related]
6. Functional significance of secreted Frizzled-related protein 1 in metastatic renal cell carcinomas. Saini S; Liu J; Yamamura S; Majid S; Kawakami K; Hirata H; Dahiya R Cancer Res; 2009 Sep; 69(17):6815-22. PubMed ID: 19723665 [TBL] [Abstract][Full Text] [Related]
7. [Influence of EphA2 siRNA transfection on the biological behavior of human ovarian carcinoma cell]. Han LP; Li MM; Zhang XX; Geng LN; Suo ZH Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Nov; 44(6):877-81. PubMed ID: 24490493 [TBL] [Abstract][Full Text] [Related]
8. Metastin inhibits migration and invasion of renal cell carcinoma with overexpression of metastin receptor. Shoji S; Tang XY; Umemura S; Itoh J; Takekoshi S; Shima M; Usui Y; Nagata Y; Uchida T; Osamura RY; Terachi T Eur Urol; 2009 Feb; 55(2):441-9. PubMed ID: 18395325 [TBL] [Abstract][Full Text] [Related]
9. Regulation of carcinoma cell invasion by protein C inhibitor whose expression is decreased in renal cell carcinoma. Wakita T; Hayashi T; Nishioka J; Tamaru H; Akita N; Asanuma K; Kamada H; Gabazza EC; Ido M; Kawamura J; Suzuki K Int J Cancer; 2004 Feb; 108(4):516-23. PubMed ID: 14696115 [TBL] [Abstract][Full Text] [Related]
10. Silencing the receptor EphA2 suppresses the growth and haptotaxis of malignant mesothelioma cells. Nasreen N; Mohammed KA; Antony VB Cancer; 2006 Nov; 107(10):2425-35. PubMed ID: 17041885 [TBL] [Abstract][Full Text] [Related]
11. Cytoplasmic Accumulation of Heterogeneous Nuclear Ribonucleoprotein K Strongly Promotes Tumor Invasion in Renal Cell Carcinoma Cells. Otoshi T; Tanaka T; Morimoto K; Nakatani T PLoS One; 2015; 10(12):e0145769. PubMed ID: 26713736 [TBL] [Abstract][Full Text] [Related]
12. Migration of renal carcinoma cells is dependent on protein kinase Cdelta via beta1 integrin and focal adhesion kinase. Brenner W; Greber I; Gudejko-Thiel J; Beitz S; Schneider E; Walenta S; Peters K; Unger R; Thüroff JW Int J Oncol; 2008 May; 32(5):1125-31. PubMed ID: 18425341 [TBL] [Abstract][Full Text] [Related]
13. Invasion in follicular thyroid cancer cell lines is mediated by EphA2 and pAkt. O'Malley Y; Lal G; Howe JR; Weigel RJ; Komorowski RA; Shilyansky J; Sugg SL Surgery; 2012 Dec; 152(6):1218-24. PubMed ID: 23158188 [TBL] [Abstract][Full Text] [Related]
14. Clusterin promotes growth and invasion of clear cell renal carcinoma cell by upregulation of S100A4 expression. Liu Y; Men C; Xu Y; Zhao K; Luo L; Dong D; Yu Q Cancer Biomark; 2018; 21(4):915-923. PubMed ID: 29400663 [TBL] [Abstract][Full Text] [Related]
15. High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma. Lyu X; Li H; Ma X; Li X; Gao Y; Ni D; Shen D; Gu L; Wang B; Zhang Y; Zhang X Cell Biochem Biophys; 2015 Jan; 71(1):279-90. PubMed ID: 25120023 [TBL] [Abstract][Full Text] [Related]
16. Comparative Gene Expression Profiling of Primary and Metastatic Renal Cell Carcinoma Stem Cell-Like Cancer Cells. Khan MI; Czarnecka AM; Lewicki S; Helbrecht I; Brodaczewska K; Koch I; Zdanowski R; Król M; Szczylik C PLoS One; 2016; 11(11):e0165718. PubMed ID: 27812180 [TBL] [Abstract][Full Text] [Related]
17. Cyclic AMP responsive element-binding protein induces metastatic renal cell carcinoma by mediating the expression of matrix metallopeptidase-2/9 and proteins associated with epithelial-mesenchymal transition. Wang X; Cui H; Lou Z; Huang S; Ren Y; Wang P; Weng G Mol Med Rep; 2017 Jun; 15(6):4191-4198. PubMed ID: 28487942 [TBL] [Abstract][Full Text] [Related]
18. Dicer is down-regulated in clear cell renal cell carcinoma and in vitro Dicer knockdown enhances malignant phenotype transformation. Ma X; Fan Y; Gao Y; Zhang Y; Huang Q; Ai Q; Ni D; Chen W; Zhang P; Song E; Wang B; Shi T; Zheng T; Zhang X Urol Oncol; 2014 Jan; 32(1):46.e9-17. PubMed ID: 24094887 [TBL] [Abstract][Full Text] [Related]
19. Expression of heparanase in renal cell carcinomas: implications for tumor invasion and prognosis. Mikami S; Oya M; Shimoda M; Mizuno R; Ishida M; Kosaka T; Mukai M; Nakajima M; Okada Y Clin Cancer Res; 2008 Oct; 14(19):6055-61. PubMed ID: 18809970 [TBL] [Abstract][Full Text] [Related]
20. RNA interference suppression of A100A4 reduces the growth and metastatic phenotype of human renal cancer cells via NF-kB-dependent MMP-2 and bcl-2 pathway. Yang XC; Wang X; Luo L; Dong DH; Yu QC; Wang XS; Zhao K Eur Rev Med Pharmacol Sci; 2013 Jun; 17(12):1669-80. PubMed ID: 23832737 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]